Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
10/19/2020
NHSA Launches Trial for Regional Point-based Global Budget and Big Dat...
10/19/2020
Immunogen and Huadong Medicine Enter Strategic Deal for Mirvetuximab ...
10/18/2020
118 Domestically-Listed MedPharm Cos Disclose Their Q3/2020 Performanc...
10/16/2020
Daiichi Sankyo Submits IND Application for ADC Medicine Enhertu (DS-82...
10/16/2020
Recent Executive Moves
10/15/2020
AffaMed Therapeutics merging with EverInsight
10/15/2020
NeoGenomics to Expand Pharma Services in China
10/15/2020
Eisai's sNDAs for Anti-Epileptic Drug Fycompa Accepted in China
10/14/2020
Hainan Announces First QFLP Fund, Insurance to Cover Foreign Anti-Canc...
10/13/2020
Overview of China's Internet-Based Medicine
10/13/2020
KBR: Medytox Suspected of Illegally Selling BTX in China
10/13/2020
Rhizen Pharma and Curon Biopharma Enter License Deal for Tenalisib in ...
10/13/2020
China: BMI Fund Cannot Afford to Cover Vaccinations
10/13/2020
SAMR Solicits Comments on the Draft Guide to Antimonopoly in the Bulk ...
10/12/2020
CDE Issues the Clinical Requirements for Drugs Marketed Outside China ...
10/11/2020
Antengene Announces Collaboration with WuXi Biologics to Advance the D...
10/10/2020
Innovent and Lilly Announce the NMPA Approval of HALPRYZA® (Rituximab...
10/10/2020
NHSA and MOF Issues Joint Notice to Advance the Trial for Inter-Provin...
10/9/2020
China Reduces VAT on A New Batch of Anticancer Drugs
10/9/2020
Recent Executive Moves
10/9/2020
NMPA Issues the Guide to Pharmaceutical Contract Manufacture Quality A...
10/8/2020
Boehringer Ingelheim Pledges Continued Direct Investments in China
10/8/2020
Lilly and Innovent Close the Expanded Global Collaboration on TYVYT (S...
10/7/2020
Harbour BioMed Announces Two NMPA IND Clearances for Phase 1 & Combo ...
10/4/2020
Q&A with Pfizer CentreOne on Contract Manufacturing for China
9/30/2020
NMPA Issues the Rules for Medical Representative Filing Management
9/30/2020
IQVIA: Chinese Hospital Drug Market Down 15.3% in Q2/2020
9/30/2020
Financial-related Company News in Brief
9/29/2020
Beijing Court Rules Over Shareholder In-fighting of Sinovac
9/29/2020
Apollomics Granted Chinese IND Approval for APL-106 in Acute Myeloid L...
Page:
105
/
357
Total number of articles:
10684
:
[First]
[<<]
[103]
[104]
[105]
[106]
[107]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit